Radiotherapy & Oncology is a peer-reviewed medical journal in the field of radiation oncology. Commonly referred to as "The Green Journal", it is published by Elsevier on behalf of the European Society for Radiotherapy and Oncology. From Wikipedia
Results from the HYPO-RT-PC Phase III trial confirm long-term safety and efficacy of ultra-hypofractionated radiotherapy, offering a transformative option for localized prostate cancer treatment.
